| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |